Home
VRTX
VRTX News

Latest Vertex Pharmaceuticals Incorporated (VRTX) News on January 19, 2025

3 Unstoppable Stocks to Buy in 2025

Motley Fool

a day ago

3 Unstoppable Stocks to Buy in 2025

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

Zacks

3 days ago

Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Motley Fool

3 days ago

Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?

Morningstar Research

4 days ago

Analyst Report: Vertex Pharmaceuticals Incorporated

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Zacks

4 days ago

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

Benzinga

5 days ago

Vertex Pharmaceuticals Sets Sight on Expanding Portfolio with Alyftrek Approval, Pain Treatment Progress, and Diabetes Trials

My 3 Highest-Conviction Growth Stocks to Buy in 2025

Motley Fool

7 days ago

My 3 Highest-Conviction Growth Stocks to Buy in 2025

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Business Wire

7 days ago

Vertex Provides Pipeline and Business Updates in Advance of Upcoming Investor Meetings

Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement

TipRanks

8 days ago

Zai Lab, Vertex Pharmaceuticals announce povetacicept license agreement

Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know

Zacks

9 days ago

Vertex Pharmaceuticals (VRTX) Stock Moves -0.62%: What You Should Know

MT Newswires

9 days ago

Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $460 From $555, Maintains Overweight Rating

INCY vs. VRTX: Which Stock Is the Better Value Option?

Zacks

9 days ago

INCY vs. VRTX: Which Stock Is the Better Value Option?

Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials

Insider Monkey

9 days ago

Vertex Pharmaceuticals Incorporated (VRTX) Slid due to Setbacks In Clinical Trials

MT Newswires

9 days ago

Vertex, Zai Lab Partner Over Povetacicept Development in China, 4 Other Regions

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Business Wire

9 days ago

Vertex and Zai Lab Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan Region and Singapore

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

Business Wire

9 days ago

Zai Lab and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Mainland China, Hong Kong SAR, Macau SAR, Taiwan region and Singapore

MT Newswires

9 days ago

Morgan Stanley Lowers Price Target on Vertex Pharmaceuticals to $456 From $476, Keeps Equalweight Rating

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% Undervalued

Simply Wall St.

9 days ago

An Intrinsic Calculation For Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Suggests It's 42% Undervalued

Vertex and Orna sign partnership to improve efficiencies of gene therapies

Pharmaceutical Technology

11 days ago

Vertex and Orna sign partnership to improve efficiencies of gene therapies

MT Newswires

12 days ago

Vertex, Orna Therapeutics Collaborate on Gene Editing Therapies for Sickle Cell Disease, Beta Thalassemia

MT Newswires

12 days ago

RBC Lifts Price Target on Vertex Pharmaceuticals to $401 From $400, Keeps Sector Perform Rating

Vertex, startup Orna to partner on gene editing research

BioPharma Dive

12 days ago

Vertex, startup Orna to partner on gene editing research

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

PR Newswire

12 days ago

Orna Therapeutics Establishes Strategic Collaboration with Vertex Pharmaceuticals to Develop Next Generation Approaches for Sickle Cell Disease (SCD) and Transfusion-Dependent Beta Thalassemia (TDT)

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

Zacks

13 days ago

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note

3 US Stocks Estimated To Be Undervalued By Up To 42%

Simply Wall St.

13 days ago

3 US Stocks Estimated To Be Undervalued By Up To 42%

Jim Cramer’s Take on Vertex Pharmaceuticals (VRTX): Bold Predictions for the Future

Insider Monkey

18 days ago

Jim Cramer’s Take on Vertex Pharmaceuticals (VRTX): Bold Predictions for the Future

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Zacks

18 days ago

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Zacks

19 days ago

Vertex Pharmaceuticals (VRTX) Advances While Market Declines: Some Information for Investors

Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) three years ago are up 79%

Simply Wall St.

19 days ago

Those who invested in Vertex Pharmaceuticals (NASDAQ:VRTX) three years ago are up 79%

Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock?

Zacks

20 days ago

Is the Options Market Predicting a Spike in Vertex Pharmaceuticals (VRTX) Stock?

Why This Beaten-Down Growth Stock Is a No-Brainer Buy on the Dip

Motley Fool

22 days ago

Why This Beaten-Down Growth Stock Is a No-Brainer Buy on the Dip

The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics

Zacks

24 days ago

The Zacks Analyst Blog Highlights T-Mobile, Toyota Motor, Vertex Pharmaceuticals, BK Technologies and Servotronics

Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip

Motley Fool

24 days ago

Vertex Pharmaceuticals Stock Is Down 13%. Here's Why You Should Buy the Dip

Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): ‘This Is Hardly Down For The Year. I Think It Can Still Go Lower’

Insider Monkey

25 days ago

Jim Cramer on Vertex Pharmaceuticals Incporated (VRTX): ‘This Is Hardly Down For The Year. I Think It Can Still Go Lower’

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

Yahoo Finance Video

25 days ago

Novo Nordisk is 'losing its pep' in GLP-1 race: BMO analyst

Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?

Insider Monkey

a month ago

Will Vertex Pharmaceuticals Incorporated (VRTX) Make You Rich In 2025?

Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know

Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals

Zacks

a month ago

Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals

Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist

TipRanks

a month ago

Vertex Pharmaceuticals price target lowered to $460 from $550 at Truist

3 No-Brainer Stocks to Buy on the Latest Sell-Off

Motley Fool

a month ago

3 No-Brainer Stocks to Buy on the Latest Sell-Off

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘Their Painkiller Equaled The Placebo. And That’s Just A Shame’

Insider Monkey

a month ago

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘Their Painkiller Equaled The Placebo. And That’s Just A Shame’

Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek

Zacks

a month ago

Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek

MT Newswires

a month ago

Truist Securities Cuts Price Target on Vertex Pharmaceuticals to $460 From $550, Keeps Buy Rating

Vertex secures two FDA wins for cystic fibrosis, both with boxed warnings

Pharmaceutical Technology

a month ago

Vertex secures two FDA wins for cystic fibrosis, both with boxed warnings

MT Newswires

a month ago

Scotiabank Adjusts Price Target on Vertex Pharmaceuticals to $430 From $426, Keeps Sector Perform Rating

MT Newswires

a month ago

JPMorgan Adjusts Price Target on Vertex Pharmaceuticals to $500 From $503, Keeps Overweight Rating

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Motley Fool

a month ago

This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy?

Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?

Motley Fool

a month ago

Should You Buy Vertex Pharmaceuticals on the Dip Before Potentially Enormous News in January 2025?

Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein

TipRanks

a month ago

Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

Motley Fool

a month ago

3 Fantastic Stocks That Could Enjoy a Santa Claus Rally

My Top 10 Stocks to Buy for 2025

Motley Fool

a month ago

My Top 10 Stocks to Buy for 2025

Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock

Investor's Business Daily

a month ago

Vertex Wins An Early Approval; Why It Might Not Move Vertex's Beleaguered Stock

MT Newswires

a month ago

Vertex Pharmaceuticals Gets Expanded FDA Approval for Trikafta

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Business Wire

a month ago

Vertex Announces US FDA Approval of ALYFTREK™, a Once-Daily Next-in-Class CFTR Modulator for the Treatment of Cystic Fibrosis

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

Business Wire

a month ago

Vertex Announces U.S. FDA Approval for TRIKAFTA (elexacaftor/tezacaftor/ivacaftor and ivacaftor) to Include Additional Non-F508del TRIKAFTA-Responsive Variants

MT Newswires

a month ago

HC Wainwright Adjusts Vertex Pharmaceuticals Price Target to $535 From $600, Maintains Buy Rating

MT Newswires

a month ago

Leerink Partners Adjusts Vertex Pharmaceuticals Price Target to $542 From $600, Maintains Outperform Rating

MT Newswires

a month ago

Bernstein Adjusts Vertex Pharmaceuticals Price Target to $441 From $506, Maintains Market Perform Rating

MT Newswires

a month ago

Barclays Adjusts Vertex Pharmaceuticals Price Target to $418 From $509, Maintains Equalweight Rating

MT Newswires

a month ago

Redburn Atlantic Adjusts Vertex Pharmaceuticals Price Target to $550 From $570, Maintains Buy Rating

Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?

Investor's Business Daily

a month ago

Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study?

Morningstar Research

a month ago

Analyst Report: Vertex Pharmaceuticals Incorporated

S&P 500 Gains and Losses Today: Darden Restaurants Stock Sizzles After Sales Beat

Investopedia

a month ago

S&P 500 Gains and Losses Today: Darden Restaurants Stock Sizzles After Sales Beat

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

Investor's Business Daily

a month ago

Vertex Dives 11% On A 'Worst-Case Scenario' For Its Non-Opioid Pain Drug

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘I Think You Should Buy The Dip Here’

Insider Monkey

a month ago

Jim Cramer on Vertex Pharmaceuticals Incorporated (VRTX): ‘I Think You Should Buy The Dip Here’

MT Newswires

a month ago

Oppenheimer Downgrades Vertex Pharmaceuticals to Market Perform From Outperform; Shares Fall

Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?

Benzinga

a month ago

Why Is Vertex Pharmaceuticals Stock Trading Lower On Thursday After Back Pain Trial Data?

Accenture, Robinhood and Coinbase, Vertex: Market Minute

Yahoo Finance Video

a month ago

Accenture, Robinhood and Coinbase, Vertex: Market Minute

MT Newswires

a month ago

RBC Capital Cuts Vertex Pharmaceuticals' Price Target to $400 From $451

MT Newswires

a month ago

Scotiabank Cuts Vertex Pharmaceuticals' Price Target to $426 From $486

Vertex Pain Drug Doesn’t Beat Placebo. The Company Says It Still Sees Promise.

Barrons.com

a month ago

Vertex Pain Drug Doesn’t Beat Placebo. The Company Says It Still Sees Promise.

Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3

Insider Monkey

a month ago

Here’s Why Vertex Pharmaceuticals Incorporated (VRTX) Slid in Q3

Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain

Investor's Business Daily

a month ago

Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Investor's Business Daily

a month ago

Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

Business Wire

a month ago

Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy

2 Unstoppable Stocks to Buy and Hold for the Next Decade

Motley Fool

a month ago

2 Unstoppable Stocks to Buy and Hold for the Next Decade

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It

4 Big Drug Stocks That May Continue to Outperform in 2025

Zacks

a month ago

4 Big Drug Stocks That May Continue to Outperform in 2025

Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today

Zacks

a month ago

Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today

BMY vs. VRTX: Which Stock Is the Better Value Option?

Zacks

a month ago

BMY vs. VRTX: Which Stock Is the Better Value Option?

MT Newswires

a month ago

Stifel Adjusts Price Target on Vertex Pharmaceuticals to $494 From $490, Maintains Hold Rating

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

Motley Fool

a month ago

Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030

3 Unstoppable Stocks to Buy Right Now

Motley Fool

a month ago

3 Unstoppable Stocks to Buy Right Now

The Ultimate Biotech Stock to Buy With $500 Right Now

Motley Fool

a month ago

The Ultimate Biotech Stock to Buy With $500 Right Now

Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Zacks

a month ago

Vertex Pharmaceuticals (VRTX) Falls More Steeply Than Broader Market: What Investors Need to Know

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

Benzinga

a month ago

Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock

2 No-Brainer Stocks to Buy Before the End of 2024

Motley Fool

a month ago

2 No-Brainer Stocks to Buy Before the End of 2024

MT Newswires

a month ago

Jefferies Upgrades Vertex Pharmaceuticals to Buy From Hold, Adjusts Price Target to $550 From $500

Gene therapy uptake in sickle cell stays slow, despite patient interest

BioPharma Dive

a month ago

Gene therapy uptake in sickle cell stays slow, despite patient interest

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

Business Wire

a month ago

Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update

3 No-Brainer Growth Stocks to Buy in December

Motley Fool

a month ago

3 No-Brainer Growth Stocks to Buy in December

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

Motley Fool

a month ago

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

3 of the Best Growth Stocks You Can Buy for Less than $100

Motley Fool

a month ago

3 of the Best Growth Stocks You Can Buy for Less than $100

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

Zacks

2 months ago

Why Is Vertex (VRTX) Down 8.6% Since Last Earnings Report?

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Zacks

2 months ago

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

Motley Fool

2 months ago

Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says May Soar More than 65%

GILD vs. VRTX: Which Stock Should Value Investors Buy Now?

Zacks

2 months ago

GILD vs. VRTX: Which Stock Should Value Investors Buy Now?

US Exchange Highlights 3 Stocks Possibly Trading Below Intrinsic Value

Simply Wall St.

2 months ago

US Exchange Highlights 3 Stocks Possibly Trading Below Intrinsic Value

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

Motley Fool

2 months ago

Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.

High Growth Tech Stocks to Watch in November 2024

Simply Wall St.

2 months ago

High Growth Tech Stocks to Watch in November 2024

Share on Social Networks: